Some scientific research tips on 96-13-9

Here is a brief introduction to this compound(96-13-9)Recommanded Product: 2,3-Dibromo-1-propanol, if you want to know about other compounds related to this compound(96-13-9), you can read my other articles.

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Irmak, Sinan; Georg, Dietmar; Lechner, Wolfgang researched the compound: 2,3-Dibromo-1-propanol( cas:96-13-9 ).Recommanded Product: 2,3-Dibromo-1-propanol.They published the article 《Comparison of CBCT conversion methods for dose calculation in the head and neck region.》 about this compound( cas:96-13-9 ) in Zeitschrift fur medizinische Physik. Keywords: Adaptive radiotherapy; CBCT based dose calculation; Deformable registration; Head and neck cancer. We’ll tell you more about this compound (cas:96-13-9).

The purpose of this study was to compare different methods of CBCT conversion respect to dose calculation accuracy. Twelve head and neck cancer patients treated with VMAT using simultaneous integrated boost technique were selected for the study. For each patient a planning CT (pCT), a control. CT acquired in the fourth week of treatment and a CBCT scan acquired on the closest day with the control CT were used. In order to re-calculate dose directly on CBCT image sets, a population based approach (CBCTPop) and a Histogram Matching (HM) approach based on rigid (CBCTHM-R) and deformable registration (CBCTHM-D) were used. Additionally, virtual CTs (vCTs) were generated using two deformable image registration algorithms (CTELX and CTANC) of the planning CT to the CBCT by using two different deformable image registration (DIR) algorithms. The corresponding control CTs were selected as ground truth and dose distributions on CBCT were analyzed using 3D global gamma index analysis applying a threshold of 10% with respect to the prescribed dose. Using the 2%/2mm gamma criterion, the results were 89.9%(±8.3%), 94.1%(±5.0%), 94.3%(±5.7%), 96.1%(±3.9%), 93.4%(±6.3%) for the CBCTPop, CBCTHM-R, CBCTHM-D, CTELX and CTANC, respectively. On average, the HM and DIR techniques showed a higher accuracy compared to the population based approach, but Kruskal-Wallis test did not show significant difference among the investigated dose calculation techniques assuming p<0.05. More sophisticated CBCT dose calculation methods seem to improve the dose calculation accuracy, but statistical significance remains to be demonstrated. Here is a brief introduction to this compound(96-13-9)Recommanded Product: 2,3-Dibromo-1-propanol, if you want to know about other compounds related to this compound(96-13-9), you can read my other articles.

Reference:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem